SecBot SecBot
COURT-RULING ·Filed Aug 31, 2026

BSX

BOSTON SCIENTIFIC CORP
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This is a minor procedural win for BSX in one of many pelvic mesh cases. It does not change the overall litigation landscape. Monitor for any class action or MDL developments, but this individual case is immaterial to BSX's financials.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$48.08
T+0 close · Sep 1, 2026 · via day close
Latest settled
−9.21%
T+20 · $43.65 · next T+60 in 8d
Vs SPY
−9.57%
α at T+20
Latest observation
−6.58%
T+52 · FF3 residual α
  1. T+0 · Sep 1 $48.08entry
  2. T+1 · 3mo ago +0.60%α +0.16% · $48.37
  3. T+5 · 2mo ago −6.49%α −6.57% · $44.96
  4. T+20 · 7w ago −9.21%α −9.57% · $43.65
  5. T+53 · todayOpen
  6. T+60 · in 8d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A federal magistrate judge barred the plaintiffs' economic expert in a single product-liability case against Boston Scientific over its Obtryx pelvic mesh sling, due to the plaintiffs' repeated failure over two years to produce tax returns needed for the defense's rebuttal. This is a procedural win for BSX in an individual case, but the ruling does not resolve liability or set precedent for the broader pelvic mesh litigation.

Court Ruling Details

Ruling Date
Aug 31, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Stacey D. Adams
Case Type
product liability
Ruling Type
discovery
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Court barred plaintiffs' economic expert Andrew Verzilli under Rule 37(c)(1) for failure to produce tax returns despite multiple court orders and extensions over two years.
  • The case is an individual product-liability action (not a class action or MDL) involving the Obtryx Transobturator Mid-Urethral Sling System.
  • No monetary damages were awarded; the ruling only limits plaintiffs' ability to present expert testimony on lost wages.
  • Boston Scientific is a $70B market cap company; this single case is immaterial to its financials.

Financial Impact

No monetary damages awarded; ruling limits plaintiffs' ability to prove lost wages in this individual case.

litigation exposurelegal costs

Risk Factors

  • Other pelvic mesh cases against BSX may proceed with expert testimony on economic damages.
  • Plaintiffs could appeal the exclusion ruling, though success is unlikely given the extensive record of non-compliance.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (38 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-85673bd292-BSX

Track record

22 reports on BSX

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Oct 28, 202619d ago 8-K Bearish 6/10 No price data
  2. Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
  3. Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
  4. Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
  5. Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
  6. Aug 31, 202611w ago Court Ruling Neutral 2/10 Viewing Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
  7. Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
  8. Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
  9. Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
  10. Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (9h 33m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Sep 1, 2026